<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36567359</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>26</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity.</ArticleTitle><Pagination><StartPage>54</StartPage><MedlinePgn>54</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">54</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-022-00332-y</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an adult-onset paralytic disease characterized by progressive degeneration of upper and lower motor neurons in the motor cortex, brainstem and spinal cord. Motor neuron degeneration is typically caused by a combination of intrinsic neuronal (cell autonomous) defects as well as extrinsic (non-cell autonomous) factors such as astrocyte-mediated toxicity. Astrocytes are highly plastic cells that react to their microenvironment to mediate relevant responses. In neurodegeneration, astrocytes often turn reactive and in turn secrete a slew of factors to exert pro-inflammatory and neurotoxic effects. Various efforts have been carried out to characterize the diseased astrocyte secretome over the years, revealing that pro-inflammatory chemokines, cytokines and microRNAs are the main players in mediating neuronal death. As metabolomic technologies mature, these studies begin to shed light on neurotoxic metabolites such as secreted lipids. In this focused review, we will discuss changes in the astrocyte secretome during ALS. In particular, we will discuss the components of the reactive astrocyte secretome that contribute to neuronal death in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Winanto</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Shi-Yan</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0003-3418-2757</Identifier><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, 138673, Singapore. syng@imcb.a-star.edu.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="Y">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000089282" MajorTopicYN="Y">Secretome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Astrocyte</Keyword><Keyword MajorTopicYN="N">Astrocyte-mediated toxicity</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Secretome</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>25</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36567359</ArticleId><ArticleId IdType="pmc">PMC9791755</ArticleId><ArticleId IdType="doi">10.1186/s40035-022-00332-y</ArticleId><ArticleId IdType="pii">10.1186/s40035-022-00332-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10(11):661&#x2013;70. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10(5):615&#x2013;22. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci. 2007;10(5):608&#x2013;14. doi: 10.1038/nn1885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29(9):824&#x2013;8. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A, Zorec R, Parpura V. Stratification of astrocytes in healthy and diseased brain. Brain Pathol. 2017;27(5):629&#x2013;44. doi: 10.1111/bpa.12537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12537</ArticleId><ArticleId IdType="pmc">PMC5599174</ArticleId><ArticleId IdType="pubmed">28805002</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Rothstein JD. Astrocyte diversity: current insights and future directions. Neurochem Res. 2020;45(6):1298&#x2013;305. doi: 10.1007/s11064-020-02959-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-02959-7</ArticleId><ArticleId IdType="pmc">PMC8715392</ArticleId><ArticleId IdType="pubmed">32006215</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezas R, Avila M, Gonzalez J, El-Bacha RS, Baez E, Garcia-Segura LM, et al. Astrocytic modulation of blood brain barrier: perspectives on Parkinson&#x2019;s disease. Front Cell Neurosci. 2014;8:211. doi: 10.3389/fncel.2014.00211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00211</ArticleId><ArticleId IdType="pmc">PMC4120694</ArticleId><ArticleId IdType="pubmed">25136294</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin KT, Eroglu C. Molecular mechanisms of astrocyte-induced synaptogenesis. Curr Opin Neurobiol. 2017;45:113&#x2013;20. doi: 10.1016/j.conb.2017.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.05.006</ArticleId><ArticleId IdType="pmc">PMC5573249</ArticleId><ArticleId IdType="pubmed">28570864</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung WS, Allen NJ, Eroglu C. Astrocytes control synapse formation, function, and elimination. Cold Spring Harb Perspect Biol. 2015;7(9):a020370. doi: 10.1101/cshperspect.a020370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020370</ArticleId><ArticleId IdType="pmc">PMC4527946</ArticleId><ArticleId IdType="pubmed">25663667</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B, Barros LF. The astrocyte: powerhouse and recycling center. Cold Spring Harb Perspect Biol. 2015;7(12):a020396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4665076</ArticleId><ArticleId IdType="pubmed">25680832</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner DA, Adamson DC. Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism. J Neuropathol Exp Neurol. 2011;70(3):167&#x2013;76. doi: 10.1097/NEN.0b013e31820e1152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31820e1152</ArticleId><ArticleId IdType="pmc">PMC3045672</ArticleId><ArticleId IdType="pubmed">21293295</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew MV. Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci. 2015;16(5):249&#x2013;63. doi: 10.1038/nrn3898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3898</ArticleId><ArticleId IdType="pmc">PMC5253239</ArticleId><ArticleId IdType="pubmed">25891508</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhy-Tselnicker I, Allen NJ. Astrocytes, neurons, synapses: a tripartite view on cortical circuit development. Neural Dev. 2018;13(1):7. doi: 10.1186/s13064-018-0104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13064-018-0104-y</ArticleId><ArticleId IdType="pmc">PMC5928581</ArticleId><ArticleId IdType="pubmed">29712572</ArticleId></ArticleIdList></Reference><Reference><Citation>Reemst K, Noctor SC, Lucassen PJ, Hol EM. The indispensable roles of microglia and astrocytes during brain development. Front Hum Neurosci. 2016;10:566. doi: 10.3389/fnhum.2016.00566.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2016.00566</ArticleId><ArticleId IdType="pmc">PMC5099170</ArticleId><ArticleId IdType="pubmed">27877121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7&#x2013;35. doi: 10.1007/s00401-009-0619-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0619-8</ArticleId><ArticleId IdType="pmc">PMC2799634</ArticleId><ArticleId IdType="pubmed">20012068</ArticleId></ArticleIdList></Reference><Reference><Citation>Phatnani H, Maniatis T. Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol. 2015;7(6):a020628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4448607</ArticleId><ArticleId IdType="pubmed">25877220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009;187(6):761&#x2013;72. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangavelu SR, Tripathi PP, Arya U, Mishra HK, Subramaniam JR. ALS associated mutant SOD1 impairs the motor neurons and astrocytes and wild type astrocyte secreted-factors reverse the impaired motor neurons. Ann Neurosci. 2011;18(2):48&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117032</ArticleId><ArticleId IdType="pubmed">25205921</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Devlin AC, Chouhan AK, Selvaraj BT, Stavrou M, Burr K, et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2020;68(5):1046&#x2013;64. doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell. 2008;3(6):637&#x2013;48. doi: 10.1016/j.stem.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.09.017</ArticleId><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Cassina P, Vargas MR, Castellanos R, Viera L, Beckman JS, et al. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem. 2004;89(2):464&#x2013;73. doi: 10.1111/j.1471-4159.2004.02357.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02357.x</ArticleId><ArticleId IdType="pubmed">15056289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff OJ, Clarke BE, Taha DM, Crerar H, Luscombe NM, Patani R. Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states. Genome Res. 2022;32(1):71&#x2013;84. doi: 10.1101/gr.275939.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.275939.121</ArticleId><ArticleId IdType="pmc">PMC8744676</ArticleId><ArticleId IdType="pubmed">34963663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sussmuth SD, Sperfeld AD, Hinz A, Brettschneider J, Endruhn S, Ludolph AC, et al. CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology. 2010;74(12):982&#x2013;7. doi: 10.1212/WNL.0b013e3181d5dc3b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181d5dc3b</ArticleId><ArticleId IdType="pubmed">20308682</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Sequeira C, Likhite S, Dennys CN, Kolb SJ, Shaw PJ, et al. Neurotoxic astrocytes directly converted from sporadic and familial ALS patient fibroblasts reveal signature diversities and miR-146a theragnostic potential in specific subtypes. Cells. 2022;11(7):1186. doi: 10.3390/cells11071186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071186</ArticleId><ArticleId IdType="pmc">PMC8997588</ArticleId><ArticleId IdType="pubmed">35406750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Sequeira C, Barbosa M, Cunha C, Vaz AR, Brites D. Astrocyte regional diversity in ALS includes distinct aberrant phenotypes with common and causal pathological processes. Exp Cell Res. 2020;395(2):112209. doi: 10.1016/j.yexcr.2020.112209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.112209</ArticleId><ArticleId IdType="pubmed">32739211</ArticleId></ArticleIdList></Reference><Reference><Citation>Karve IP, Taylor JM, Crack PJ. The contribution of astrocytes and microglia to traumatic brain injury. Br J Pharmacol. 2016;173(4):692&#x2013;702. doi: 10.1111/bph.13125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13125</ArticleId><ArticleId IdType="pmc">PMC4742296</ArticleId><ArticleId IdType="pubmed">25752446</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyvarinen T, Hagman S, Ristola M, Sukki L, Veijula K, Kreutzer J, et al. Co-stimulation with IL-1beta and TNF-alpha induces an inflammatory reactive astrocyte phenotype with neurosupportive characteristics in a human pluripotent stem cell model system. Sci Rep. 2019;9(1):16944. doi: 10.1038/s41598-019-53414-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-53414-9</ArticleId><ArticleId IdType="pmc">PMC6858358</ArticleId><ArticleId IdType="pubmed">31729450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KM, MacLean AG. New advances on glial activation in health and disease. World J Virol. 2015;4(2):42&#x2013;55. doi: 10.5501/wjv.v4.i2.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v4.i2.42</ArticleId><ArticleId IdType="pmc">PMC4419121</ArticleId><ArticleId IdType="pubmed">25964871</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Liu T, Chen X, Li L, Feng M, Zhang Y, et al. Microglia induce the transformation of A1/A2 reactive astrocytes via the CXCR7/PI3K/Akt pathway in chronic post-surgical pain. J Neuroinflamm. 2020;17(1):211. doi: 10.1186/s12974-020-01891-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01891-5</ArticleId><ArticleId IdType="pmc">PMC7362409</ArticleId><ArticleId IdType="pubmed">32665021</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481&#x2013;7. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Li J, Zheng J, Qin S. Reactive astrocytes in neurodegenerative diseases. Aging Dis. 2019;10(3):664&#x2013;75. doi: 10.14336/AD.2018.0720.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2018.0720</ArticleId><ArticleId IdType="pmc">PMC6538217</ArticleId><ArticleId IdType="pubmed">31165009</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005;120(3):421&#x2013;33. doi: 10.1016/j.cell.2004.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.12.020</ArticleId><ArticleId IdType="pubmed">15707899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa K, Pham LD, Arai K, Lo EH. Reactive astrocytes promote adhesive interactions between brain endothelium and endothelial progenitor cells via HMGB1 and beta-2 integrin signaling. Stem Cell Res. 2014;12(2):531&#x2013;8. doi: 10.1016/j.scr.2013.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2013.12.008</ArticleId><ArticleId IdType="pmc">PMC3966549</ArticleId><ArticleId IdType="pubmed">24480450</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C, Galea E, Lakatos A, O&#x2019;Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312&#x2013;25. doi: 10.1038/s41593-020-00783-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00783-4</ArticleId><ArticleId IdType="pmc">PMC8007081</ArticleId><ArticleId IdType="pubmed">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong XY, Tang Y, Yang QW. Metabolic changes favor the activity and heterogeneity of reactive astrocytes. Trends Endocrinol Metab. 2022;33(6):390&#x2013;400. doi: 10.1016/j.tem.2022.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2022.03.001</ArticleId><ArticleId IdType="pubmed">35396164</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann K, Sepulveda-Falla D, Rose IVL, Madore C, Muth C, Matschke J, et al. Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia. Acta Neuropathol Commun. 2019;7(1):83. doi: 10.1186/s40478-019-0735-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0735-1</ArticleId><ArticleId IdType="pmc">PMC6530067</ArticleId><ArticleId IdType="pubmed">31118110</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke LE, Liddelow SA, Chakraborty C, Munch AE, Heiman M, Barres BA. Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci U S A. 2018;115(8):E1896-E905. doi: 10.1073/pnas.1800165115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800165115</ArticleId><ArticleId IdType="pmc">PMC5828643</ArticleId><ArticleId IdType="pubmed">29437957</ArticleId></ArticleIdList></Reference><Reference><Citation>Cekanaviciute E, Dietrich HK, Axtell RC, Williams AM, Egusquiza R, Wai KM, et al. Astrocytic TGF-beta signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. J Immunol. 2014;193(1):139&#x2013;49. doi: 10.4049/jimmunol.1303284.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303284</ArticleId><ArticleId IdType="pmc">PMC4075480</ArticleId><ArticleId IdType="pubmed">24860191</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz LP, Tortelli V, Matias I, Morgado J, Bergamo Araujo AP, Melo HM, et al. Astrocyte transforming growth factor beta 1 protects synapses against Abeta oligomers in Alzheimer&#x2019;s disease model. J Neurosci. 2017;37(28):6797&#x2013;809. doi: 10.1523/JNEUROSCI.3351-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3351-16.2017</ArticleId><ArticleId IdType="pmc">PMC6596548</ArticleId><ArticleId IdType="pubmed">28607171</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao T, Ji H, Shangguan X, Qu S, Cui Y, Xu J. NLRP3 inflammasome of microglia promotes A1 astrocyte transformation, neo-neuron decline and cognition impairment in endotoxemia. Biochem Biophys Res Commun. 2022;602:1&#x2013;7. doi: 10.1016/j.bbrc.2022.02.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2022.02.092</ArticleId><ArticleId IdType="pubmed">35247698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou B, Zhang Y, Liang P, He Y, Peng B, Liu W, et al. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Cell Death Dis. 2020;11(5):377. doi: 10.1038/s41419-020-2565-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2565-2</ArticleId><ArticleId IdType="pmc">PMC7229224</ArticleId><ArticleId IdType="pubmed">32415059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian H, Yang L, Cole A, Sun L, Chiang AC, Fowler SW, et al. NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer&#x2019;s disease. Neuron. 2015;85(1):101&#x2013;15. doi: 10.1016/j.neuron.2014.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.11.018</ArticleId><ArticleId IdType="pmc">PMC4289109</ArticleId><ArticleId IdType="pubmed">25533482</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Dupre N, Petri S, Strong M, Kriz J, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappab-mediated pathogenic pathways. J Exp Med. 2011;208(12):2429&#x2013;47. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HY, Wang Y, He Y, Wang T, Huang XH, Zhao CM, et al. A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment. J Neuroinflammation. 2020;17(1):200. doi: 10.1186/s12974-020-01871-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01871-9</ArticleId><ArticleId IdType="pmc">PMC7331266</ArticleId><ArticleId IdType="pubmed">32611425</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon R, Neal ML, Luo J, Langley MR, Harischandra DS, Panicker N, et al. Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration. Nat Commun. 2016;7:12932. doi: 10.1038/ncomms12932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12932</ArticleId><ArticleId IdType="pmc">PMC5059486</ArticleId><ArticleId IdType="pubmed">27703142</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal M, Luo J, Harischandra DS, Gordon R, Sarkar S, Jin H, et al. Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes. Glia. 2018;66(10):2137&#x2013;57. doi: 10.1002/glia.23467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23467</ArticleId><ArticleId IdType="pmc">PMC6240381</ArticleId><ArticleId IdType="pubmed">30277602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323(5918):1205&#x2013;8. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Graffmo K, Pakkenberg B, Weber M, Nielsen M, Marklund S, et al. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes. J Neurol Neurosurg Psychiatry. 2019;90(8):861&#x2013;9. doi: 10.1136/jnnp-2018-319386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319386</ArticleId><ArticleId IdType="pmc">PMC6691870</ArticleId><ArticleId IdType="pubmed">30992335</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci Res. 2018;126:31&#x2013;8. doi: 10.1016/j.neures.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125(6):777&#x2013;94. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Kim HJ. Prion-like mechanism in amyotrophic lateral sclerosis: are protein aggregates the Key? Exp Neurobiol. 2015;24(1):1&#x2013;7. doi: 10.5607/en.2015.24.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.1.1</ArticleId><ArticleId IdType="pmc">PMC4363329</ArticleId><ArticleId IdType="pubmed">25792864</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M, Romano V, Quadri Z, Buratti E, Baralle FE. TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain. Hum Mol Genet. 2015;24(1):9&#x2013;20. doi: 10.1093/hmg/ddu415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu415</ArticleId><ArticleId IdType="pmc">PMC4262490</ArticleId><ArticleId IdType="pubmed">25122661</ArticleId></ArticleIdList></Reference><Reference><Citation>Che MX, Jiang YJ, Xie YY, Jiang LL, Hu HY. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing. FASEB J. 2011;25(7):2344&#x2013;53. doi: 10.1096/fj.10-174482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-174482</ArticleId><ArticleId IdType="pubmed">21450909</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRocca TJ, Mariani A, Watkins LR, Link CD. TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol Dis. 2019;132:104514. doi: 10.1016/j.nbd.2019.104514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104514</ArticleId><ArticleId IdType="pmc">PMC6834892</ArticleId><ArticleId IdType="pubmed">31229690</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng AYT, Agrawal I, Ho WY, Yen YC, Pinter AJ, Liu J, et al. Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction. Proc Natl Acad Sci U S A. 2020;117(46):29101&#x2013;12. doi: 10.1073/pnas.2007806117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2007806117</ArticleId><ArticleId IdType="pmc">PMC7682406</ArticleId><ArticleId IdType="pubmed">33127758</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou TW, Chang NP, Krishnagiri M, Patel AP, Lindman M, Angel JP, et al. Fibrillar alpha-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-kappaB. Cell Death Dis. 2021;12(8):756. doi: 10.1038/s41419-021-04049-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-04049-0</ArticleId><ArticleId IdType="pmc">PMC8325686</ArticleId><ArticleId IdType="pubmed">34333522</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009;284(30):20329&#x2013;39. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Kim S, Kang HY, Lim HR, Kwon Y, Jo M, et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J Neuroinflamm. 2020;17(1):299. doi: 10.1186/s12974-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>White JA, Manelli AM, Holmberg KH, Van Eldik LJ, Ladu MJ. Differential effects of oligomeric and fibrillar amyloid-beta 1&#x2013;42 on astrocyte-mediated inflammation. Neurobiol Dis. 2005;18(3):459&#x2013;65. doi: 10.1016/j.nbd.2004.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2004.12.013</ArticleId><ArticleId IdType="pubmed">15755672</ArticleId></ArticleIdList></Reference><Reference><Citation>French RL, Grese ZR, Aligireddy H, Dhavale DD, Reeb AN, Kedia N, et al. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation. J Biol Chem. 2019;294(17):6696&#x2013;709. doi: 10.1074/jbc.RA118.005889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005889</ArticleId><ArticleId IdType="pmc">PMC6497947</ArticleId><ArticleId IdType="pubmed">30824544</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirie E, Oh CK, Zhang X, Han X, Cieplak P, Scott HR, et al. S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD. Proc Natl Acad Sci U S A. 2021;118(11):e2021368118. doi: 10.1073/pnas.2021368118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2021368118</ArticleId><ArticleId IdType="pmc">PMC7980404</ArticleId><ArticleId IdType="pubmed">33692125</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, Risse E, Tyzack GE, Mitchell JS, Taha DM, Chen YR, et al. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Brain. 2020;143(2):430&#x2013;40. doi: 10.1093/brain/awz419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz419</ArticleId><ArticleId IdType="pmc">PMC7009461</ArticleId><ArticleId IdType="pubmed">32040555</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangwan S, Zhao A, Adams KL, Jayson CK, Sawaya MR, Guenther EL, et al. Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS) Proc Natl Acad Sci U S A. 2017;114(33):8770&#x2013;5. doi: 10.1073/pnas.1705091114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1705091114</ArticleId><ArticleId IdType="pmc">PMC5565441</ArticleId><ArticleId IdType="pubmed">28760994</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirooznia SK, Dawson VL, Dawson TM. Motor neuron death in ALS: programmed by astrocytes? Neuron. 2014;81(5):961&#x2013;3. doi: 10.1016/j.neuron.2014.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.02.024</ArticleId><ArticleId IdType="pmc">PMC4040524</ArticleId><ArticleId IdType="pubmed">24607221</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P, Rodriguez-Muela N, Klim JR, de Boer AS, Agrawal S, Sandoe J, et al. Reactive astrocytes promote als-like degeneration and intracellular protein aggregation in human motor neurons by disrupting autophagy through TGF-beta1. Stem Cell Rep. 2017;9(2):667&#x2013;80. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A, Ning K, Heath PR, Wood E, Kirby J, Fusi N, et al. Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol. 2013;125(1):95&#x2013;109. doi: 10.1007/s00401-012-1058-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1058-5</ArticleId><ArticleId IdType="pmc">PMC3535376</ArticleId><ArticleId IdType="pubmed">23143228</ArticleId></ArticleIdList></Reference><Reference><Citation>King AE, Woodhouse A, Kirkcaldie MT, Vickers JC. Excitotoxicity in ALS: overstimulation, or overreaction? Exp Neurol. 2016;275(1):162&#x2013;71. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh PN, Meldrum BS. Excitotoxicity in ALS. Neurology. 1996;47(6 Suppl 4):221-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8959993</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh Y, Takahashi Y. Riluzole for the treatment of amyotrophic lateral sclerosis. Neurodegener Dis Manag. 2020;10(6):343&#x2013;55. doi: 10.2217/nmt-2020-0033.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt-2020-0033</ArticleId><ArticleId IdType="pubmed">32847483</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews JA, Jackson CE, Heiman-Patterson TD, Bettica P, Brooks BR, Pioro EP. Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemp Degener. 2020;21(7&#x2013;8):509&#x2013;18. doi: 10.1080/21678421.2020.1771734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1771734</ArticleId><ArticleId IdType="pubmed">32573277</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing G, Edaravone ALSSG. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16(7):505&#x2013;12. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia AE, Lalli S, Monsurro MR, Sagnelli A, Taiello AC, Reggiori B, et al. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. Eur J Neurol. 2016;23(1):45&#x2013;52. doi: 10.1111/ene.12664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12664</ArticleId><ArticleId IdType="pmc">PMC5024041</ArticleId><ArticleId IdType="pubmed">25664595</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, Andres PL, Macdonald SA, Bedlack RS, Choudry R, Brown RH, Jr, et al. Phase 2 study of sodium phenylbutyrate in ALS. Amyotroph Lateral Scler. 2009;10(2):99&#x2013;106. doi: 10.1080/17482960802320487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802320487</ArticleId><ArticleId IdType="pubmed">18688762</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Hendrix S, Dickson SP, Knowlton N, Berry JD, Elliott MA, et al. Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial. J Neurol Neurosurg Psychiatry. 2022;93(8):871&#x2013;5. doi: 10.1136/jnnp-2022-329024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-329024</ArticleId><ArticleId IdType="pmc">PMC9304116</ArticleId><ArticleId IdType="pubmed">35577511</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher P, van Leyen K, Dey PN, Honrath B, Dolga A, Methner A. The role of ca(2+) in cell death caused by oxidative glutamate toxicity and ferroptosis. Cell Calcium. 2018;70:47&#x2013;55. doi: 10.1016/j.ceca.2017.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2017.05.007</ArticleId><ArticleId IdType="pmc">PMC5682235</ArticleId><ArticleId IdType="pubmed">28545724</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagami CJ, O&#x2019;Shea RD, Lau CL, Cheema SS, Beart PM. Regulation of glutamate transporters in astrocytes: evidence for a relationship between transporter expression and astrocytic phenotype. Neurotox Res. 2005;7(1&#x2013;2):143&#x2013;9. doi: 10.1007/BF03033783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03033783</ArticleId><ArticleId IdType="pubmed">15639805</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman DL, Behar KL, Hyder F, Shulman RG. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol. 2003;65:401&#x2013;27. doi: 10.1146/annurev.physiol.65.092101.142131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.physiol.65.092101.142131</ArticleId><ArticleId IdType="pubmed">12524459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanamori K, Kondrat RW, Ross BD. 13&#xa0;C enrichment of extracellular neurotransmitter glutamate in rat brain&#x2013;combined mass spectrometry and NMR studies of neurotransmitter turnover and uptake into glia in vivo. Cell Mol Biol (Noisy-le-grand) 2003;49(5):819&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">14528919</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeks JP, Mennerick S. Astrocyte membrane responses and potassium accumulation during neuronal activity. Hippocampus. 2007;17(11):1100&#x2013;8. doi: 10.1002/hipo.20344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.20344</ArticleId><ArticleId IdType="pubmed">17853441</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosli L, Andres PF, Hosli E. Depolarization of cultured astrocytes by glutamate and aspartate. Neuroscience. 1979;4(11):1593&#x2013;8. doi: 10.1016/0306-4522(79)90022-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(79)90022-8</ArticleId><ArticleId IdType="pubmed">514509</ArticleId></ArticleIdList></Reference><Reference><Citation>Parpura V, Zorec R, Gliotransmission Exocytotic release from astrocytes. Brain Res Rev. 2010;63(1&#x2013;2):83&#x2013;92. doi: 10.1016/j.brainresrev.2009.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2009.11.008</ArticleId><ArticleId IdType="pmc">PMC2862866</ArticleId><ArticleId IdType="pubmed">19948188</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci. 2002;193(2):73&#x2013;8. doi: 10.1016/S0022-510X(01)00661-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00661-X</ArticleId><ArticleId IdType="pubmed">11790386</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D, Brambilla L, Valori CF, Roncoroni C, Crugnola A, Yokota T, et al. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 2008;15(11):1691&#x2013;700. doi: 10.1038/cdd.2008.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.99</ArticleId><ArticleId IdType="pubmed">18617894</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S, et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci U S A. 2014;111(2):829&#x2013;32. doi: 10.1073/pnas.1314085111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A, Ben-Dor I, Ottolenghi M, Turetsky T, Gil Y, Sweetat S, et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;89. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpurohit CS, Kumar V, Cheffer A, Oliveira D, Ulrich H, Okamoto OK, et al. Mechanistic insights of astrocyte-mediated hyperactive autophagy and loss of motor neuron function in SOD1(L39R) linked amyotrophic lateral sclerosis. Mol Neurobiol. 2020;57(10):4117&#x2013;33. doi: 10.1007/s12035-020-02006-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02006-0</ArticleId><ArticleId IdType="pubmed">32676988</ArticleId></ArticleIdList></Reference><Reference><Citation>Skorupa A, Urbach S, Vigy O, King MA, Chaumont-Dubel S, Prehn JH, et al. Angiogenin induces modifications in the astrocyte secretome: relevance to amyotrophic lateral sclerosis. J Proteom. 2013;91:274&#x2013;85. doi: 10.1016/j.jprot.2013.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2013.07.028</ArticleId><ArticleId IdType="pubmed">23920243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A, McAvoy K, Krishnamurthy K, Trotti D, Pasinelli P. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia. 2018;66(5):1016&#x2013;33. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R, Zecca C, Piccininni M, Benmahamed S, Dell&#x2019;Abate MT, Barulli MR, et al. Plasma inflammatory cytokines are elevated in ALS. Front Neurol. 2020;11:552295. doi: 10.3389/fneur.2020.552295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.552295</ArticleId><ArticleId IdType="pmc">PMC7691268</ArticleId><ArticleId IdType="pubmed">33281700</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SS, Lee HJ, Lim I, Satoh J, Kim SU. Human astrocytes: secretome profiles of cytokines and chemokines. PLoS ONE. 2014;9(4):e92325. doi: 10.1371/journal.pone.0092325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092325</ArticleId><ArticleId IdType="pmc">PMC3972155</ArticleId><ArticleId IdType="pubmed">24691121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N, Schurr C, Olde Heuvel F, Tang L, Li Q, Tasdogan A, et al. NF-kappaB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J. 2018;37:16. doi: 10.15252/embj.201798697.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798697</ArticleId><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Dhull DK, Nalini A, Vijayalakshmi K, Sathyaprabha TN, Alladi PA, et al. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J Neuroinflamm. 2016;13(1):212. doi: 10.1186/s12974-016-0698-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0698-0</ArticleId><ArticleId IdType="pmc">PMC5006495</ArticleId><ArticleId IdType="pubmed">27578023</ArticleId></ArticleIdList></Reference><Reference><Citation>Izrael M, Slutsky SG, Admoni T, Cohen L, Granit A, Hasson A, et al. Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1(G93A) and NSG animal models. Stem Cell Res Ther. 2018;9(1):152. doi: 10.1186/s13287-018-0890-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-0890-5</ArticleId><ArticleId IdType="pmc">PMC5989413</ArticleId><ArticleId IdType="pubmed">29871694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosito M, Deflorio C, Limatola C, Trettel F. CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS. J Neurosci. 2012;32(9):3154&#x2013;63. doi: 10.1523/JNEUROSCI.4046-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4046-11.2012</ArticleId><ArticleId IdType="pmc">PMC6622038</ArticleId><ArticleId IdType="pubmed">22378888</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, Ditsworth D, Sun S, Song S, Liang J, Hruska-Plochan M, et al. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron. 2015;86(1):218&#x2013;32. doi: 10.1016/j.neuron.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.02.034</ArticleId><ArticleId IdType="pmc">PMC4393372</ArticleId><ArticleId IdType="pubmed">25801706</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan KA, Weigel MK, Adler DI, Couthouis J, Liddelow SA, Gitler AD, et al. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat Commun. 2020;11(1):3753. doi: 10.1038/s41467-020-17514-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17514-9</ArticleId><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11(3):251&#x2013;3. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Velebit J, Horvat A, Smolic T, Prpar Mihevc S, Rogelj B, Zorec R, et al. Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and ca(2+) signaling and dysregulated cell metabolism. Sci Rep. 2020;10(1):6003. doi: 10.1038/s41598-020-62864-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62864-5</ArticleId><ArticleId IdType="pmc">PMC7138839</ArticleId><ArticleId IdType="pubmed">32265469</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho AB, Pinto IFD, Dantas LS, Xavier AM, Inague A, Faria RL, et al. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci Rep. 2019;9(1):11642. doi: 10.1038/s41598-019-48059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48059-7</ArticleId><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Lee JJ, Park NY, Dubey SK, Kim T, Ruan K, et al. Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nat Neurosci. 2021;24(12):1673&#x2013;85. doi: 10.1038/s41593-021-00944-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00944-z</ArticleId><ArticleId IdType="pmc">PMC8639773</ArticleId><ArticleId IdType="pubmed">34782793</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton KA, Brown MV, Alexander D, Li Z, Wulff JE, Lawson R, et al. Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotroph Lateral Scler Frontotemp Degener. 2014;15(5&#x2013;6):362&#x2013;70. doi: 10.3109/21678421.2014.908311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.908311</ArticleId><ArticleId IdType="pubmed">24984169</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore SA, Yoder E, Murphy S, Dutton GR, Spector AA. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6) J Neurochem. 1991;56(2):518&#x2013;24. doi: 10.1111/j.1471-4159.1991.tb08180.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1991.tb08180.x</ArticleId><ArticleId IdType="pubmed">1824862</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella N, Tence M, Glowinski J, Premont J. Glutamate-evoked release of arachidonic acid from mouse brain astrocytes. J Neurosci. 1994;14(2):568&#x2013;75. doi: 10.1523/JNEUROSCI.14-02-00568.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.14-02-00568.1994</ArticleId><ArticleId IdType="pmc">PMC6576829</ArticleId><ArticleId IdType="pubmed">7507979</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumuis A, Pin JP, Oomagari K, Sebben M, Bockaert J. Arachidonic acid released from striatal neurons by joint stimulation of ionotropic and metabotropic quisqualate receptors. Nature. 1990;347(6289):182&#x2013;4. doi: 10.1038/347182a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/347182a0</ArticleId><ArticleId IdType="pubmed">1975645</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumuis A, Sebben M, Fagni L, Prezeau L, Manzoni O, Cragoe EJ, Jr, et al. Stimulation by glutamate receptors of arachidonic acid release depends on the Na+/Ca2+ exchanger in neuronal cells. Mol Pharmacol. 1993;43(6):976&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">7686247</ArticleId></ArticleIdList></Reference><Reference><Citation>Almer G, Teismann P, Stevic Z, Halaschek-Wiener J, Deecke L, Kostic V, et al. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology. 2002;58(8):1277&#x2013;9. doi: 10.1212/WNL.58.8.1277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.58.8.1277</ArticleId><ArticleId IdType="pubmed">11971099</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilzecka J. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2003;108(2):125&#x2013;9. doi: 10.1034/j.1600-0404.2003.00102.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2003.00102.x</ArticleId><ArticleId IdType="pubmed">12859290</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q, Hu Q, Wang H, Yang H, Gao F, Ren H, et al. Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia. Cell Death Dis. 2015;6:e1702. doi: 10.1038/cddis.2015.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.69</ArticleId><ArticleId IdType="pmc">PMC4385945</ArticleId><ArticleId IdType="pubmed">25811799</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou YH, Guan PP, Zhang SQ, Guo YS, Wang P. Rofecoxib attenuates the pathogenesis of amyotrophic lateral sclerosis by alleviating cyclooxygenase-2-mediated mechanisms. Front Neurosci. 2020;14:817. doi: 10.3389/fnins.2020.00817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00817</ArticleId><ArticleId IdType="pmc">PMC7438558</ArticleId><ArticleId IdType="pubmed">32903591</ArticleId></ArticleIdList></Reference><Reference><Citation>Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2003;17(6):725&#x2013;7. doi: 10.1096/fj.02-0876fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.02-0876fje</ArticleId><ArticleId IdType="pubmed">12586733</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan KA, Weigel MK, Prakash P, Wijewardhane PR, Hasel P, Rufen-Blanchette U, et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. 2021;599(7883):102&#x2013;7. doi: 10.1038/s41586-021-03960-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03960-y</ArticleId><ArticleId IdType="pubmed">34616039</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, Jensen EH, Yu J, Sardi SP, Bialas AR, Taksir TV, et al. Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis. J Neurosci. 2020;40(47):9137&#x2013;47. doi: 10.1523/JNEUROSCI.1388-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1388-20.2020</ArticleId><ArticleId IdType="pmc">PMC7673008</ArticleId><ArticleId IdType="pubmed">33051352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharbi T, Zhang Z, Yang GY. The function of astrocyte mediated extracellular vesicles in central nervous system diseases. Front Cell Dev Biol. 2020;8:568889. doi: 10.3389/fcell.2020.568889.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.568889</ArticleId><ArticleId IdType="pmc">PMC7593543</ArticleId><ArticleId IdType="pubmed">33178687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun C, Smith AST, Kim H, Kamenz DS, Lee JH, Lee JB, et al. Astrocyte-derived extracellular vesicles enhance the survival and electrophysiological function of human cortical neurons in vitro. Biomaterials. 2021;271:120700. doi: 10.1016/j.biomaterials.2021.120700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2021.120700</ArticleId><ArticleId IdType="pmc">PMC8044026</ArticleId><ArticleId IdType="pubmed">33631652</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri AD, Dastgheyb RM, Yoo SW, Trout A, Talbot CC, Jr, Hao H, et al. TNFalpha and IL-1beta modify the miRNA cargo of astrocyte shed extracellular vesicles to regulate neurotrophic signaling in neurons. Cell Death Dis. 2018;9(3):363. doi: 10.1038/s41419-018-0369-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0369-4</ArticleId><ArticleId IdType="pmc">PMC5838212</ArticleId><ArticleId IdType="pubmed">29507357</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Sheng S, Wang Y, Ding L, Xu X, Xia X, et al. Astrocyte-derived extracellular vesicles: a double-edged sword in central nervous system disorders. Neurosci Biobehav Rev. 2021;125:148&#x2013;59. doi: 10.1016/j.neubiorev.2021.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2021.02.027</ArticleId><ArticleId IdType="pubmed">33626395</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y, Borgmann K, Edara VV, Stacy S, Ghorpade A, Ikezu T. Activated human astrocyte-derived extracellular vesicles modulate neuronal uptake, differentiation and firing. J Extracell Vesicles. 2020;9(1):1706801. doi: 10.1080/20013078.2019.1706801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2019.1706801</ArticleId><ArticleId IdType="pmc">PMC6968484</ArticleId><ArticleId IdType="pubmed">32002171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Xia K, Chen L, Fan D. Increased interleukin-6 levels in the astrocyte-derived exosomes of sporadic amyotrophic lateral sclerosis patients. Front Neurosci. 2019;13:574. doi: 10.3389/fnins.2019.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00574</ArticleId><ArticleId IdType="pmc">PMC6560167</ArticleId><ArticleId IdType="pubmed">31231184</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman JM, Christy D, Shyu CC, Moon KM, Fernando S, Gidden Z, et al. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)(G93A) ALS mice originate from astrocytes and neurons and carry misfolded SOD1. J Biol Chem. 2019;294(10):3744&#x2013;59. doi: 10.1074/jbc.RA118.004825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004825</ArticleId><ArticleId IdType="pmc">PMC6416428</ArticleId><ArticleId IdType="pubmed">30635404</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, et al. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211(4):897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A, Myszczynska MA, Castelli LM, O&#x2019;Neill B, Kim Y, Talbot J, et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;35. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Keene SD, Greco TM, Parastatidis I, Lee SH, Hughes EG, Balice-Gordon RJ, et al. Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretome. Proteomics. 2009;9(3):768&#x2013;82. doi: 10.1002/pmic.200800385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200800385</ArticleId><ArticleId IdType="pmc">PMC2667946</ArticleId><ArticleId IdType="pubmed">19132682</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore NH, Costa LG, Shaffer SA, Goodlett DR, Guizzetti M. Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation. J Neurochem. 2009;108(4):891&#x2013;908. doi: 10.1111/j.1471-4159.2008.05836.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05836.x</ArticleId><ArticleId IdType="pmc">PMC2754805</ArticleId><ArticleId IdType="pubmed">19077055</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco TM, Seeholzer SH, Mak A, Spruce L, Ischiropoulos H. Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion. J Proteome Res. 2010;9(5):2764&#x2013;74. doi: 10.1021/pr100134n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr100134n</ArticleId><ArticleId IdType="pmc">PMC2866110</ArticleId><ArticleId IdType="pubmed">20329800</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedl TJ, San Gil R, Cheng F, Rayner SL, Davidson JM, De Luca A, et al. Proteomics approaches for biomarker and drug target discovery in ALS and FTD. Front Neurosci. 2019;13:548. doi: 10.3389/fnins.2019.00548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00548</ArticleId><ArticleId IdType="pmc">PMC6579929</ArticleId><ArticleId IdType="pubmed">31244593</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber CN, Raben DM. Lipid metabolism crosstalk in the brain: glia and neurons. Front Cell Neurosci. 2019;13:212. doi: 10.3389/fncel.2019.00212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00212</ArticleId><ArticleId IdType="pmc">PMC6536584</ArticleId><ArticleId IdType="pubmed">31164804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou MS, Jackson J, Sheu SH, Chang CL, Weigel AV, Liu H, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell. 2019;177(6):1522&#x2013;35. doi: 10.1016/j.cell.2019.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.04.001</ArticleId><ArticleId IdType="pubmed">31130380</ArticleId></ArticleIdList></Reference><Reference><Citation>Staurenghi E, Giannelli S, Testa G, Sottero B, Leonarduzzi G, Gamba P. Cholesterol dysmetabolism in Alzheimer&#x2019;s disease: a starring role for astrocytes? Antioxidants (Basel). 2021;10(12):1890. doi: 10.3390/antiox10121890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10121890</ArticleId><ArticleId IdType="pmc">PMC8750262</ArticleId><ArticleId IdType="pubmed">34943002</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc S, Kurnaz IA, Ozilgen M. Astrocyte-neuron lactate shuttle may boost more ATP supply to the neuron under hypoxic conditions&#x2013;in silico study supported by in vitro expression data. BMC Syst Biol. 2011;5:162. doi: 10.1186/1752-0509-5-162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-5-162</ArticleId><ArticleId IdType="pmc">PMC3202240</ArticleId><ArticleId IdType="pubmed">21995951</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali C, Tauffenberger A, Magistretti P. The strategic location of glycogen and lactate: from body energy reserve to brain plasticity. Front Cell Neurosci. 2019;13:82. doi: 10.3389/fncel.2019.00082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00082</ArticleId><ArticleId IdType="pmc">PMC6415680</ArticleId><ArticleId IdType="pubmed">30894801</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason S. Lactate shuttles in neuroenergetics-homeostasis, allostasis and beyond. Front Neurosci. 2017;11:43. doi: 10.3389/fnins.2017.00043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00043</ArticleId><ArticleId IdType="pmc">PMC5288365</ArticleId><ArticleId IdType="pubmed">28210209</ArticleId></ArticleIdList></Reference><Reference><Citation>Belanger M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14(6):724&#x2013;38. doi: 10.1016/j.cmet.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.08.016</ArticleId><ArticleId IdType="pubmed">22152301</ArticleId></ArticleIdList></Reference><Reference><Citation>Descalzi G, Gao V, Steinman MQ, Suzuki A, Alberini CM. Lactate from astrocytes fuels learning-induced mRNA translation in excitatory and inhibitory neurons. Commun Biol. 2019;2:247. doi: 10.1038/s42003-019-0495-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0495-2</ArticleId><ArticleId IdType="pmc">PMC6606643</ArticleId><ArticleId IdType="pubmed">31286064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Wang Y, Chen ST, Chen YJ, Shen J, Yao WB, et al. Modulation of the astrocyte-neuron lactate shuttle system contributes to neuroprotective action of fibroblast growth factor 21. Theranostics. 2020;10(18):8430&#x2013;45. doi: 10.7150/thno.44370.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.44370</ArticleId><ArticleId IdType="pmc">PMC7381735</ArticleId><ArticleId IdType="pubmed">32724479</ArticleId></ArticleIdList></Reference><Reference><Citation>Afridi R, Kim JH, Rahman MH, Suk K. Metabolic regulation of glial phenotypes: implications in neuron-glia interactions and neurological disorders. Front Cell Neurosci. 2020;14:20. doi: 10.3389/fncel.2020.00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00020</ArticleId><ArticleId IdType="pmc">PMC7026370</ArticleId><ArticleId IdType="pubmed">32116564</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Houten B. Huntington&#x2019;s disease: astrocytes shift to fatty acid metabolism. Trends Endocrinol Metab. 2019;30(9):575&#x2013;7. doi: 10.1016/j.tem.2019.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2019.07.019</ArticleId><ArticleId IdType="pubmed">31399292</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer BC, Kluemper J, Johnson LA. Apolipoprotein E4 alters astrocyte fatty acid metabolism and lipid droplet formation. Cells. 2019;8(2):182. doi: 10.3390/cells8020182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8020182</ArticleId><ArticleId IdType="pmc">PMC6406677</ArticleId><ArticleId IdType="pubmed">30791549</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell JA, Johnson JA, Li L. Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics. J Proteome Res. 2009;8(8):4135&#x2013;43. doi: 10.1021/pr900248y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr900248y</ArticleId><ArticleId IdType="pmc">PMC2866504</ArticleId><ArticleId IdType="pubmed">19469553</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella R, Bonadio RS, Cagnin S, Massimino ML, Bertoli A, Peggion C. Perturbations of the proteome and of secreted metabolites in primary astrocytes from the hSOD1(G93A) ALS mouse model. Int J Mol Sci. 2021;22(13):7028. doi: 10.3390/ijms22137028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22137028</ArticleId><ArticleId IdType="pmc">PMC8268687</ArticleId><ArticleId IdType="pubmed">34209958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjbar Taklimie F, Gasterich N, Scheld M, Weiskirchen R, Beyer C, Clarner T, et al. Hypoxia induces astrocyte-derived Lipocalin-2 in ischemic stroke. Int J Mol Sci. 2019;20(6):1271. doi: 10.3390/ijms20061271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20061271</ArticleId><ArticleId IdType="pmc">PMC6471434</ArticleId><ArticleId IdType="pubmed">30871254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BW, Jeong KH, Kim JH, Jin M, Kim JH, Lee MG, et al. Pathogenic upregulation of glial Lipocalin-2 in the parkinsonian dopaminergic system. J Neurosci. 2016;36(20):5608&#x2013;22. doi: 10.1523/JNEUROSCI.4261-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4261-15.2016</ArticleId><ArticleId IdType="pmc">PMC6601774</ArticleId><ArticleId IdType="pubmed">27194339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q, et al. Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci U S A. 2013;110(10):4069&#x2013;74. doi: 10.1073/pnas.1218497110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218497110</ArticleId><ArticleId IdType="pmc">PMC3593910</ArticleId><ArticleId IdType="pubmed">23431168</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesquita SD, Ferreira AC, Falcao AM, Sousa JC, Oliveira TG, Correia-Neves M, et al. Lipocalin 2 modulates the cellular response to amyloid beta. Cell Death Differ. 2014;21(10):1588&#x2013;99. doi: 10.1038/cdd.2014.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.68</ArticleId><ArticleId IdType="pmc">PMC4158684</ArticleId><ArticleId IdType="pubmed">24853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk K. Lipocalin-2 as a therapeutic target for brain injury: an astrocentric perspective. Prog Neurobiol. 2016;144:158&#x2013;72. doi: 10.1016/j.pneurobio.2016.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.08.001</ArticleId><ArticleId IdType="pubmed">27498195</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, Kim JH, Jang E, Lee YM, Soo Han H, Woo DK, et al. Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab. 2014;34(8):1306&#x2013;14. doi: 10.1038/jcbfm.2014.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.83</ArticleId><ArticleId IdType="pmc">PMC4126090</ArticleId><ArticleId IdType="pubmed">24780901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore KI, Berard JL, Redensek A, Chierzi S, Lopez-Vales R, Santos M, et al. Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury. J Neurosci. 2011;31(38):13412&#x2013;9. doi: 10.1523/JNEUROSCI.0116-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0116-11.2011</ArticleId><ArticleId IdType="pmc">PMC6623298</ArticleId><ArticleId IdType="pubmed">21940434</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens V, Voelz C, Muller N, Zhao W, Gasterich N, Clarner T, et al. Lipocalin 2 as a putative modulator of local inflammatory processes in the spinal cord and component of organ cross talk after spinal cord injury. Mol Neurobiol. 2021;58(11):5907&#x2013;19. doi: 10.1007/s12035-021-02530-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02530-7</ArticleId><ArticleId IdType="pubmed">34417948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei H, Wu X, You Y, Duran RC, Zheng Y, Narayanan KL, et al. Systematic analysis of purified astrocytes after SCI unveils Zeb2os function during astrogliosis. Cell Rep. 2021;34(5):108721. doi: 10.1016/j.celrep.2021.108721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108721</ArticleId><ArticleId IdType="pmc">PMC7920574</ArticleId><ArticleId IdType="pubmed">33535036</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G, Leigh PN, Newbury SF, Hafezparast M. An overview of MicroRNAs as biomarkers of ALS. Front Neurol. 2019;10:186. doi: 10.3389/fneur.2019.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00186</ArticleId><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C, Marzocchi C, Battistini S. MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells. 2018;7(11):219. doi: 10.3390/cells7110219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7110219</ArticleId><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Madathil SK, Nelson PT, Saatman KE, Wilfred BR. MicroRNAs in CNS injury: potential roles and therapeutic implications. BioEssays. 2011;33(1):21&#x2013;6. doi: 10.1002/bies.201000069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201000069</ArticleId><ArticleId IdType="pmc">PMC3033010</ArticleId><ArticleId IdType="pubmed">21053309</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro V, Yakoub KM, Scarpa U, Di Pietro C, Belli A. MicroRNA signature of traumatic brain injury: from the biomarker discovery to the point-of-care. Front Neurol. 2018;9:429. doi: 10.3389/fneur.2018.00429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00429</ArticleId><ArticleId IdType="pmc">PMC6010584</ArticleId><ArticleId IdType="pubmed">29963002</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica L, Todeasa SH, Cabrera GT, Salameh JS, ElMallah MK, Mueller C, et al. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model. Ann Neurol. 2016;79(4):687&#x2013;700. doi: 10.1002/ana.24618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24618</ArticleId><ArticleId IdType="pmc">PMC5374859</ArticleId><ArticleId IdType="pubmed">26891182</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen GM, Gowing G, Latter J, Chen M, Vit JP, Staggenborg K, et al. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J Neurosci. 2014;34(47):15587&#x2013;600. doi: 10.1523/JNEUROSCI.2037-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2037-14.2014</ArticleId><ArticleId IdType="pmc">PMC4298650</ArticleId><ArticleId IdType="pubmed">25411487</ArticleId></ArticleIdList></Reference><Reference><Citation>Martier R, Liefhebber JM, Garcia-Osta A, Miniarikova J, Cuadrado-Tejedor M, Espelosin M, et al. Targeting RNA-mediated toxicity in C9orf72 ALS and/or FTD by RNAi-based gene therapy. Mol Ther Nucleic Acids. 2019;16:26&#x2013;37. doi: 10.1016/j.omtn.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.02.001</ArticleId><ArticleId IdType="pmc">PMC6393708</ArticleId><ArticleId IdType="pubmed">30825670</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark BS, Blackshaw S. Understanding the role of lncRNAs in nervous system development. Adv Exp Med Biol. 2017;1008:253&#x2013;82. doi: 10.1007/978-981-10-5203-3_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-10-5203-3_9</ArticleId><ArticleId IdType="pmc">PMC5890441</ArticleId><ArticleId IdType="pubmed">28815543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629&#x2013;41. doi: 10.1016/j.cell.2009.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.02.006</ArticleId><ArticleId IdType="pubmed">19239885</ArticleId></ArticleIdList></Reference><Reference><Citation>He B, Chen W, Zeng J, Tong W, Zheng P. Long noncoding RNA NKILA transferred by astrocyte-derived extracellular vesicles protects against neuronal injury by upregulating NLRX1 through binding to mir-195 in traumatic brain injury. Aging. 2021;13(6):8127&#x2013;45. doi: 10.18632/aging.202618.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.202618</ArticleId><ArticleId IdType="pmc">PMC8034961</ArticleId><ArticleId IdType="pubmed">33686956</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Tang J. LncRNA Gm14205 induces astrocytic NLRP3 inflammasome activation via inhibiting oxytocin receptor in postpartum depression. Biosci Rep. 2020;40(8):BSR20200672. doi: 10.1042/BSR20200672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20200672</ArticleId><ArticleId IdType="pmc">PMC7414522</ArticleId><ArticleId IdType="pubmed">32706026</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav RS, Tiwari NK. Lipid integration in neurodegeneration: an overview of Alzheimer&#x2019;s disease. Mol Neurobiol. 2014;50(1):168&#x2013;76. doi: 10.1007/s12035-014-8661-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8661-5</ArticleId><ArticleId IdType="pubmed">24590317</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombelli C, Aoun M, Tiranti V. Defective lipid metabolism in neurodegeneration with brain iron accumulation (NBIA) syndromes: not only a matter of iron. J Inherit Metab Dis. 2015;38(1):123&#x2013;36. doi: 10.1007/s10545-014-9770-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-014-9770-z</ArticleId><ArticleId IdType="pubmed">25300979</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer BC, Walsh AE, Kluemper JC, Johnson LA. Lipid droplets in neurodegenerative disorders. Front Neurosci. 2020;14:742. doi: 10.3389/fnins.2020.00742.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00742</ArticleId><ArticleId IdType="pmc">PMC7403481</ArticleId><ArticleId IdType="pubmed">32848541</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Veyrat-Durebex C, Bocca C, Patin F, Vourc&#x2019;h P, Kouassi Nzoughet J, et al. Lipidomics reveals cerebrospinal-fluid signatures of ALS. Sci Rep. 2017;7(1):17652. doi: 10.1038/s41598-017-17389-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17389-9</ArticleId><ArticleId IdType="pmc">PMC5732162</ArticleId><ArticleId IdType="pubmed">29247199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, et al. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD) J Biol Chem. 2012;287(25):21384&#x2013;95. doi: 10.1074/jbc.M112.340513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.340513</ArticleId><ArticleId IdType="pmc">PMC3375560</ArticleId><ArticleId IdType="pubmed">22532571</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>